---
title: "Vivos Therapeutics Inc Full Year Sales Increase"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282925793.md"
description: "Vivos Therapeutics Inc (VVOS) reported a full-year loss of $21.17 million, or $2.07 per share, compared to a loss of $11.14 million, or $2.22 per share, the previous year. However, the company's revenue increased by 16.0% to $17.44 million from $15.03 million last year. Key figures include earnings of -$21.17 million, EPS of -$2.07, and revenue of $17.44 million."
datetime: "2026-04-16T02:20:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282925793.md)
  - [en](https://longbridge.com/en/news/282925793.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282925793.md)
---

# Vivos Therapeutics Inc Full Year Sales Increase

(RTTNews) - Vivos Therapeutics Inc (VVOS) released Loss for full year of -$21.17 million

The company's earnings came in at -$21.17 million, or -$2.07 per share. This compares with -$11.14 million, or -$2.22 per share, last year.

The company's revenue for the period rose 16.0% to $17.44 million from $15.03 million last year.

Vivos Therapeutics Inc earnings at a glance (GAAP) :

\-Earnings: -$21.17 Mln. vs. -$11.14 Mln. last year. -EPS: -$2.07 vs. -$2.22 last year. -Revenue: $17.44 Mln vs. $15.03 Mln last year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

### Related Stocks

- [VVOS.US](https://longbridge.com/en/quote/VVOS.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)
- [Stryker Buys Amplitude Vascular Systems For Upto $835 Mln To Expand Vascular Treatment Business](https://longbridge.com/en/news/286889480.md)
- [Boston Scientific Targets Growing Aortic Stenosis Market With $1.5 Billion Deal](https://longbridge.com/en/news/286808399.md)
- [Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain | MDT Stock News](https://longbridge.com/en/news/287072903.md)
- [Harvest Portfolios Group Inc. Grows Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/287027124.md)